Previous 10 | Next 10 |
EAST RUTHERFORD, N.J., Sept. 23, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM) (the “Company” or “Cambrex”) today announced the expiration, as of 12:01 a.m., Eastern Time, on September 22, 2019, of the 45-day “go shop” period under the pr...
NEW YORK, NY / ACCESSWIRE / September 20, 2019 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Cambrex Corporation ( CBM ) ("Cambrex")...
NEW YORK, NY / ACCESSWIRE / September 10, 2019 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Cambrex Corporation (NYSE: ...
NEW YORK, NY / ACCESSWIRE / August 15, 2019 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: ...
Merger activity increased last week with seven new deals announced and four pending deals closing. In the context of the merger of Sprint (S) with T-Mobile (TMUS), it was interesting to see a large insider purchase by the Chairman of DISH Network (DISH). Deal Statistics: New Deals: ...
NEW YORK , Aug. 9, 2019 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City , is investigating: Genomic Health, Inc. ( GHDX ) ("Genomic"...
Cambrex (NYSE: CBM ) is scheduled to announce Q2 earnings results on Friday, August 9th, before market open. The consensus EPS Estimate is $0.43 (-41.9% Y/Y) and the consensus Revenue Estimate is $156.44M (+2.9% Y/Y). Over the last 2 years, CBM has beaten EPS estimates 63% of th...
EAST RUTHERFORD, N.J., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, today announced that it will not hold a second quarter 2019 earnings ...
Gainers: Cambrex Corporation (NYSE: CBM ) +47% . Weight Watchers International (NASDAQ: WW ) +40% . Paratek Pharmaceuticals (NASDAQ: PRTK ) +35% . Owens & Minor (NYSE: OMI ) +29% . Match Group (NASDAQ: MTCH ) +27% . SolarEdge Technologies (NASDAQ: SEDG ) +24% . Guardant Hea...
NEW YORK, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Cambrex Corporation (NYSE: CBM) to an affiliate of the Permira funds (“Permira”) for $60.00 per share is fair to Cambrex shareholders. O...
News, Short Squeeze, Breakout and More Instantly...
Cambrex Corporation Company Name:
CBM Stock Symbol:
NYSE Market:
ENGLEWOOD CLIFFS, N.J., July 11, 2024 (GLOBE NEWSWIRE) -- ConnectOne Bancorp, Inc. (Nasdaq: CNOB) (the “Company” or “ConnectOne”), parent company of ConnectOne Bank (the “Bank”), today announced that it plans to release results for the second quarter ende...
ENGLEWOOD CLIFFS, N.J., June 11, 2024 (GLOBE NEWSWIRE) -- ConnectOne Bank (“ConnectOne”), the wholly-owned depository subsidiary of ConnectOne Bancorp, Inc. (NASDAQ: CNOB), today announces the addition of seasoned financial services consultant Susan O’Donnell to its Board of ...
ENGLEWOOD CLIFFS. N.J., April 25, 2024 (GLOBE NEWSWIRE) -- ConnectOne Bancorp, Inc. (Nasdaq: CNOB) (the “Company” or “ConnectOne”), parent company of ConnectOne Bank (the “Bank”), today reported net income available to common stockholders of $15.7 million...